Status:
RECRUITING
Prospective Study of Serum Marker LncRNA RP5-977B1 in Pulmonary Nodules
Lead Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Conditions:
Tumor of Lung
Pulmonary Nodule
Eligibility:
All Genders
15-75 years
Brief Summary
Based on previous studies, this project intends to use prospective studies to select patients identified by imaging as pulmonary nodules to explore the potential of RP5-977B1 in differentiating benign...
Detailed Description
For the purpose of clinical diagnosis, disease monitoring, treatment or prognosis assessment, patients with pulmonary nodules may need to draw blood for routine laboratory tests several times during d...
Eligibility Criteria
Inclusion
- Pulmonary nodules were detected by imaging and surgically resected.
- Age 15-75 years old.
- Surgery or puncture is to be performed for pathological diagnosis.
- Adequate hematological function and liver and kidney function reserve. ⑤ The sample has no hemolysis, sufficient margin, and the source record is clear and can be checked.
Exclusion
- Patient samples have hemolysis, have been contaminated, have been placed for too long, have insufficient sample allowance, and record mixed samples.
- History of malignant tumor. ③ Serious underlying diseases and complications may affect systemic treatment. ④ Can not guarantee to receive blood tests on time. ⑤ Received anti-tumor Chinese medicine, immunization, chemotherapy and other treatments within 2 weeks.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06531850
Start Date
January 1 2024
End Date
January 1 2026
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital & Affiliated Guangzhou Medical University
Guangzhou, Guangdong, China, 510095